KEWAUNEE SCIENTIFIC CORP /DE/

For the period ended Apr 30, 2026. Filed Jun 26, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Jun 26, 2026

KEQU$33.72-1.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

KEWAUNEE SCIENTIFIC CORPORATION
By:	/s/ Thomas D. Hull III
	Thomas D. Hull III
	President and Chief Executive Officer

Date: June 26, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities indicated on June 26, 2026.

/s/ David S. Rhind
(i)	Principal Executive Officer
	/s/ Thomas D. Hull III
	Thomas D. Hull III
	President and Chief Executive Officer
(ii)	Principal Financial and Accounting Officer
	/s/ Donald T. Gardner III
	Donald T. Gardner III
	Vice President, Finance
	Chief Financial Officer,
	Treasurer and Secretary
(iii)	A majority of the Board of Directors:
/s/ Keith M. Gehl		/s/ John D. Russell
Keith M. Gehl		John D. Russell
/s/ Margaret B. Pyle		/s/ Donald F. Shaw
Margaret B. Pyle		Donald F. Shaw
/s/ Thomas D. Hull, III		/s/ J. Jette Campbell
Thomas D. Hull, III		J. Jette Campbell
David S. Rhind

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.